Written Question·Department of Health and Social Care·UIN 73656

Prostate Cancer: Hormone Treatments

Tabled: 1 September 2025
Answered: 19 September 2025

Question

Danny Beales

LabourUxbridge and South Ruislip

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2025 to Question 64681 on Prostate Cancer: Hormone Treatments, for what reason recurrent headroom in revenue budgets is considered a barrier to implementing the abi

Answer

Dr Zubir Ahmed
Reimbursement of abiraterone across all indications is managed at a national level by NHS England who must ensure the affordability of introducing any new routine commissioning policies, alongside maintaining existing services for patients and meeting the...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 73656) →